Access our Faculty and Staff Directory Click on the provided links to directly get in touch with our team members.
Discover the Journey of Our Program and understand how its excellence was forged through a distinctive collaboration.
Hear Directly from Our Alumni and learn about their journey through the BME Paris Master’s program.
The BME-Paris Master is designed to provide a 2-year education program in the field of bioengineering, at the crossroad of biomedical and engineering sciences
Read all rules thoroughly
17
Mar
2021
« Medical and scientific integrity in the time of COVID-19 » by Nathan Peiffer-Smadja, M.D. at 6 pm
Dr Nathan Peiffer-Smadja is a consultant (Chef de Clinique des universités – Assistant des hôpitaux) in Infectious Diseases in Bichat Claude Bernard Hospital and he is doing a PhD on the evaluation and implementation of clinical decision support systems for antimicrobial prescribing. He has been involved in the care of patients with COVID-19 since the beginning of the pandemic and in multiple research projets on COVID-19 history and therapeutics. He is an investigator of Solidarity, the international WHO clinical trial for the evaluation of COVID-19 treatments and a member of the steering committee of DisCoVeRy, the European add-on trial of Solidarity. He has been vocal in the media about the necessity to respect scientific methods and rigour when evaluating drugs even for a new and pandemic diseaseenMedical and scientific integritation of the cursus.
« Nepotistic journals’: a survey of biomedical journals » by Clara Locher, Pharm.D., Ph.D. at 7 pm
Dr Clara Locher is an assistant professor (Praticien Hospitalier Universitaire) in clinical pharmacology in Rennes Hospital University. She serves as a methodologist on various grant applications and teaches medical students and Public Health master’s students in several areas: pharmacology, methodology of clinical trials, and information science. Her research interests are (i) quality, transparency and reproducibility of trials studying targeted therapy in oncology and (ii) integrity in scientific publishing.